318 filings
Page 9 of 16
8-K
bocr200 zkq
29 Jul 14
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results
12:00am
8-K
g73x1w3yq
17 Jul 14
Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company
12:00am
8-K
c76 shtsrp69z46
23 Jun 14
Anthera Pharmaceuticals Appoints Brian R. Mueller to Board of Directors
12:00am
8-K
w30kieof2y
13 Jun 14
Anthera Pharmaceuticals Appoints Dr. Philip Sager to Board of Directors
12:00am
S-8
dnelt8uul4
13 Jun 14
Registration of securities for employees
12:00am
8-K
fano9i0jo9y9vrv3t05
13 May 14
Anthera Pharmaceuticals Reports 2014 First Quarter Financial Results
12:00am
DEFA14A
qybzdaxl
29 Apr 14
Additional proxy soliciting materials
12:00am
8-K
aizomuzjxpmx07p9qk9
31 Mar 14
Departure of Directors or Certain Officers
12:00am
8-K
fif54ci
12 Mar 14
Anthera Pharmaceuticals Reports 2013 Fourth Quarter And Fiscal Year Financial Results
12:00am
8-K
vtmsa0jp71
23 Dec 13
Departure of Directors or Certain Officers
12:00am
424B5
2z3r8akjtmr
15 Nov 13
Prospectus supplement for primary offering
12:00am
8-K
knfpt w02hhsw
15 Nov 13
Entry into a Material Definitive Agreement
12:00am
8-K
lhf ajx0xd3et4oc2ma
29 Oct 13
Clinical and Regulatory Update
12:00am
8-K
ob65jnyn rn
4 Sep 13
Changes in Registrant's Certifying Accountant
12:00am
8-K
ott67b
30 Jul 13
Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
12:00am